You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Last Updated: May 8, 2021

DrugPatentWatch Database Preview

Nexus Pharms Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for NEXUS PHARMS, and what generic and branded alternatives to NEXUS PHARMS drugs are available?

NEXUS PHARMS has thirteen approved drugs.

Summary for Nexus Pharms

US Patents:	0
Tradenames:	15
Ingredients:	13
NDAs:	13

Drugs and US Patents for Nexus Pharms

+ Get email alerts for changes to this table

Subscribe to access the full database, or Get Started for $10
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Nexus Pharms	EMERPHED	ephedrine sulfate	SOLUTION;INTRAVENOUS	213407-001	Apr 17, 2020		RX	Yes	Yes		Get Started for $10				Get Started for $10
Nexus Pharms	POTASSIUM CHLORIDE 10MEQ	potassium chloride	INJECTABLE;INJECTION	214727-001	Mar 18, 2021	AP	RX	No	No		Get Started for $10				Get Started for $10
Nexus Pharms	TESTOSTERONE ENANTHATE	testosterone enanthate	INJECTABLE;INJECTION	040575-001	Jun 14, 2006	AO	RX	No	No		Get Started for $10				Get Started for $10
Nexus Pharms	POTASSIUM CHLORIDE 20MEQ	potassium chloride	INJECTABLE;INJECTION	214727-003	Mar 18, 2021	AP	RX	No	No		Get Started for $10				Get Started for $10
Nexus Pharms	POTASSIUM CHLORIDE 10MEQ	potassium chloride	INJECTABLE;INJECTION	214727-002	Mar 18, 2021	AP	RX	No	No		Get Started for $10				Get Started for $10
Nexus Pharms	DICYCLOMINE HYDROCHLORIDE	dicyclomine hydrochloride	INJECTABLE;INJECTION	206468-001	Feb 1, 2019	AP	RX	No	No		Get Started for $10				Get Started for $10
Nexus Pharms	PROCAINAMIDE HYDROCHLORIDE	procainamide hydrochloride	INJECTABLE;INJECTION	206332-002	Oct 13, 2017	AP	RX	No	No		Get Started for $10				Get Started for $10
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Nexus Pharms

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck

Baxter

Dow

Johnson and Johnson

Mallinckrodt

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.